Keebeck Alpha, LP Pfizer Inc Transaction History

Keebeck Alpha, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 01, 2023	BUY	$46.53 - $55.17 $56,627 - $67,141	1,217 Added 7.47%	17,513 $918,000
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $56,627 - $67,141	1,217 Added 7.47%	17,513 $918,000
Q1 2022 Feb 01, 2023	SELL	$45.75 - $56.69 $55,677 - $68,991	-1,217 Reduced 6.95%	16,296 $844,000
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $224,450 - $332,710	5,432 Added 50.0%	16,296 $962,000
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $363,618 - $462,371	10,864 New	10,864 $400,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.